Asylia Therapeutics, Inc.

0 followers


Asylia Therapeutics is a biotech company focused on novel immune-modulating therapies for autoimmune, cancer, and infectious diseases.The company's platform centers on a drug pipeline capable of modulating antigen presentation to the immune system which has produced unprecedented anti-tumor response... Read more

Employees

1-10

Links

Org chart

Richard Jones, Ph.D.
Director Translational Biology

Richard Jones, Ph.D.

Collapse
John Miller
Senior Principal Scientist
Parth Mangrolia, PhD
Senior Scientist, Preclinical Development

Teams

This company has no teams yet